Related Experiment Video
Updated: Jan 23, 2026

Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor LATS Biosensor
Published on: September 13, 2018
Hippo Pathway in Cancer: Aberrant Regulation and Therapeutic Opportunities
Philamer C Calses1, James J Crawford2, Jennie R Lill3
1Department of Discovery Oncology, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA; Department of Microchemistry, Proteomics, and Lipidomics, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA.
Abstract:
The Hippo pathway remains a central focus in both basic and translational research and is a key modulator of developmental biology. Dysregulation of the pathway is associated with a plethora of human cancers and there are multiple efforts to target key components of the pathway for disease intervention. In this review, we briefly highlight the latest research advances around the core components of the Hippo pathway in cancer. More specifically, we discuss several genetic aberrations of these factors as mechanisms for the development of cancers, including genetic amplification, deletion, and gene fusions. Additionally, we highlight the role of the Hippo pathway in cancer therapy resistance and tumor immunogenicity. Last, we summarize the ongoing efforts to target the pathway in cancers.
Insights
The Hippo pathway regulates development and its dysregulation drives cancer. This review covers Hippo pathway's role in cancer genetics, therapy resistance, and immunogenicity, summarizing therapeutic targeting efforts.
Area of Science:
- Oncology
- Molecular Biology
- Developmental Biology
Background:
- The Hippo pathway is crucial for organ size control and development.
- Its dysregulation is implicated in numerous human cancers.
- Targeting the Hippo pathway is a key strategy for cancer intervention.
Purpose of the Study:
- To review recent advances in understanding the Hippo pathway in cancer.
- To discuss genetic aberrations affecting Hippo pathway components in tumorigenesis.
- To explore the Hippo pathway's role in cancer therapy resistance and immunogenicity.
Main Methods:
- Literature review of recent research on the Hippo pathway and cancer.
- Analysis of genetic alterations (amplification, deletion, fusion) in Hippo pathway genes.
- Examination of studies on Hippo pathway's influence on therapeutic response and anti-tumor immunity.
Main Results:
- Genetic aberrations in core Hippo pathway factors are mechanisms of cancer development.
- The Hippo pathway influences resistance to cancer therapies.
- Hippo pathway activity impacts tumor immunogenicity.
Conclusions:
- The Hippo pathway is a significant factor in cancer biology, affecting development and progression.
- Understanding its genetic underpinnings and roles in therapy resistance and immunity is vital.
- Targeting the Hippo pathway holds promise for novel cancer treatments.
Related Concept Videos
GTPases and their Regulation
Large G-proteins,...
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Epigenetic Regulation
Therapeutic Index
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...

